References in periodicals archive ?
Implanted through a minimally invasive lateral approach with dedicated instrumentation, the LLC was designed for the treatment of degenerative disc disease and instability, including grade 1 spondylolisthesis or retrolisthesis.
The TM Ardis Interbody System is indicated for use with autogenous bone graft as an intervertebral body fusion device at one or two contiguous levels in the lumbosacral region (L2-S1) in the treatment of degenerative disc disease (DDD) with up to Grade 1 spondylolisthesis or retrolisthesis at the involved level (s).